Intermittent Fasting: Is the Wait Worth the Weight?
Purpose of Review
We review the underlying mechanisms and potential benefits of intermittent fasting (IF) from animal models and recent clinical trials.
Numerous variations of IF exist, and study protocols vary greatly in their interpretations of this weight loss trend. Most human IF studies result in minimal weight loss and marginal improvements in metabolic biomarkers, though outcomes vary. Some animal models have found that IF reduces oxidative stress, improves cognition, and delays aging. Additionally, IF has anti-inflammatory effects, promotes autophagy, and benefits the gut microbiome. The benefit-to-harm ratio varies by model, IF protocol, age at initiation, and duration.
We provide an integrated perspective on potential benefits of IF as well as key areas for future investigation. In clinical trials, caloric restriction and IF result in similar degrees of weight loss and improvement in insulin sensitivity. Although these data suggest that IF may be a promising weight loss method, IF trials have been of moderate sample size and limited duration. More rigorous research is needed.
KeywordsIntermittent fasting Fasting Obesity Calorie restriction Metabolism Insulin resistance Weight loss
Intermittent calorie restriction
Alternate-day energy restriction
Continuous energy restriction
Randomized controlled trial
Glucose infusion rate
Reactive oxygen species
- ad lib
This work was supported in part by the National Institutes of Health [UL1TR001430, P30DK046200, T32DK007201].
Compliance with Ethical Standards
Conflict of Interest
Mary-Catherine Stockman declares that she has no conflict of interest.
Dylan Thomas declares that he has no conflict of interest.
Jacquelyn Burke declares that she has no conflict of interest.
Caroline M. Apovian has received research funding through grants from Sanofi-Aventis, Orexigen, Aspire Bariatrics, GI Dynamics, MYOS, Takeda, Gelesis, Vela Foundation, Dr. Robert C. and Veronica Atkins Foundation, Coherence Lab, Energesis, Patient-Centered Outcomes Research Institute (PCORI), the National Institutes of Health (NIH), Eli Lilly, and MetaPrteomics LLC; has received compensation from Nutrisystem, Zafgen, Sanofi-Aventis, Orexigen, Novo Nordisk, GI Dynamics, Takeda, Scientific Intake, Gelesis, Merck, Johnson & Johnson, Amylin, EnteroMedics, Arena Pharmaceuticals, Rhythm Pharmaceuticals, and Xeno Biosciences for service on advisory boards; and owns stock in Science-Smart LLC.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.•• St-Onge M-P, Ard J, Baskin ML, Chiuve SE, Johnson HM, Kris-Etherton P, et al. Meal timing and frequency: implications for cardiovascular disease prevention: a scientific statement from the American Heart Association. Circulation. 2017;135:e96–121. https://doi.org/10.1161/CIR.0000000000000476. This statement provides an up-to-date review of the effects of meal timing on cardiovascular disease risk.
- 9.Gropper S, Smith J. Integration and regulation of metabolism and the impact of exercise and sport. In: Feldman E, Cronin S, Myers M, editors. Advanced nutrition and human metabolism. Wadsworth, Cengage Learning. 2013. p. 256–9.Google Scholar
- 11.Azzout B, Bois-Joyeux B, Chanez M, Peret J. Development of gluconeogenesis from various precursors in isolated rat hepatocytes during starvation or after feeding a high protein, carbohydrate-free diet. J Nutr. 1987;117:164–9. Available from: http://jn.nutrition.org/content/117/1/164.short.CrossRefPubMedGoogle Scholar
- 12.Cahill GF. Fuel metabolism in starvation. Annu Rev Nutr. 2006;26:1–22. https://doi.org/10.1146/annurev.nutr.26.061505.111258.CrossRefPubMedGoogle Scholar
- 14.Stannard SR, Thompson MW, Fairbairn K, Huard B, Sachinwalla T, Thompson CH, et al. Fasting for 72 h increases intramyocellular lipid content in nondiabetic, physically fit men. Am. J. Physiol. Metab.. American Physiological Society. 2002;283:E1185–91. https://doi.org/10.1152/ajpendo.00108.2002.Google Scholar
- 15.• Anton SD, Moehl K, Donahoo WT, Marosi K, Lee SA, Mainous AG, et al. Flipping the metabolic switch: understanding and applying the health benefits of fasting. Obesity. 2017. This review synthesizes the animal and human data on the metabolic benefits of fasting.Google Scholar
- 16.Bass J, Lazar MA. Circadian time signatures of fitness and disease. Science. 2016;354(80):994–9. Available from: http://science.sciencemag.org/content/354/6315/994.abstract.CrossRefPubMedGoogle Scholar
- 19.• Byrne NMM, Sainsbury A, King NA, Hills AP, Wood RE. Intermittent energy restriction improves weight loss efficiency in obese men: the MATADOR study. Int. J. Obes.. 2017;42(2):129–8. https://doi.org/10.1038/ijo.2017.206 This recent RCT of ICR and CER in males found that REE decreased to a greater extent in the ICR group, suggesting that IF without CR may lead to weight gain.
- 20.Harvie M, Wright C, Pegington M, McMullan D, Mitchell E, Martin B, et al. The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br. J. Nutr. 2013;110:1534–47. Available from: https://www.cambridge.org/core/article/effect-of-intermittent-energy-and-carbohydrate-restriction-v-daily-energy-restriction-on-weight-loss-and-metabolic-disease-risk-markers-in-overweight-women/BC03063A5D8E9446D5090DB083A4B226.CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes. 2011;35:714–27.Google Scholar
- 23.•• Trepanowski JF, Kroeger CM, Barnosky A, Klempel MC, Bhutani S, Hoddy KK, et al. Effect of alternate-day fasting on weight loss, weight maintenance, and cardioprotection among metabolically healthy obese adults. JAMA Intern Med. 2017;177:930–8. https://doi.org/10.1001/jamainternmed.2017.0936 This study showed minimal between group differences, though dropout rate in the ADF group (38%) was one of the highest observed in this review.
- 24.Trepanowski JF, Kroeger CM, Barnosky A, Klempel M, Bhutani S, Hoddy KK, et al. Effects of alternate-day fasting or daily calorie restriction on body composition, fat distribution, and circulating adipokines: Secondary analysis of a randomized controlled trial. Clin. Nutr. Elsevier; 2017.Google Scholar
- 29.Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Haus JM, et al. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial. Nutr J. 2013;12:146.Google Scholar
- 31.• Catenacci VA, Pan Z, Ostendorf D, Brannon S, Gozansky WS, Mattson MP, et al. A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity. 2016;24:1874–83. Changes in fat mass and FFM were more favorable in the ADF group than in the CR group.Google Scholar
- 32.Harder-Lauridsen NM, Nielsen ST, Mann SP, Lyngbæk MP, Benatti FB, Langkilde AR, et al. The effect of alternate-day caloric restriction on the metabolic consequences of 8 days of bed rest in healthy lean men: a randomized trial. J Appl Physiol. 2017;122:230–41. https://doi.org/10.1152/japplphysiol.00846.2016.
- 35.• Barnosky AR, Kroeger CM, Trepanowski JF, Bhutani S, Hoddy KK, Gabel K, et al. Effect of alternate day fasting on markers of bone metabolism: an exploratory analysis of a 6-month randomized controlled trial. Nutr Heal Aging2 IOS Press. 2017;4:255–63. Insulin resistance decreased to a greater extent, independent of a change in lean mass, in the ADF group over the CR group. CrossRefGoogle Scholar
- 41.Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med. 2007;42:665–74. https://doi.org/10.1016/j.freeradbiomed.2006.12.005.CrossRefPubMedGoogle Scholar
- 42.Mattson MP, Longo VD, Harvie M. Impact of intermittent fasting on health and disease processes. Ageing Res. Rev. 2017;39:46–58. Available from: http://www.sciencedirect.com/science/article/pii/S1568163716302513.CrossRefPubMedGoogle Scholar
- 43.Wan R, Ahmet I, Brown M, Cheng A, Kamimura N, Talan M, et al. Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats. J Nutr Biochem. 2010;21:413–7. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2854256&tool=pmcentrez&rendertype=abstract.
- 45.• Antoni R, Johnston KL, Collins AL, Robertson MD. Investigation into the acute effects of total and partial energy restriction on postprandial metabolism among overweight/obese participants. Br J Nutr. 2016;115:951–9. This study suggests that CER could alter cardiometabolic risk independent of weight change.CrossRefPubMedGoogle Scholar
- 46.Horne BD, Muhlestein JB, May HT, Carlquist JF, Lappé DL, Bair TL, et al. Relation of routine, periodic fasting to risk of diabetes mellitus, and coronary artery disease in patients undergoing coronary angiography. Am J Cardiol. 2012;109:1558–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22425331%5Cn, http://www.sciencedirect.com/science/article/pii/S0002914912005954.
- 47.Gomez-Pinilla F. The influences of diet and exercise on mental health through hormesis. Ageing Res. Rev. 2008;7(1):49–62. https://doi.org/10.1016/j.arr.2007.04.003.
- 51.Anson RM, Guo Z, de Cabo R, Iyun T, Rios M, Hagepanos A, et al. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci. 2003;100:6216–20. https://doi.org/10.1073/pnas.1035720100.
- 52.Goodrick CL, Ingram DK, Reynolds MA, Freeman JR, Cider N. Effects of intermittent feeding upon body weight and lifespan in inbred mice: interaction of genotype and age. Mech Ageing Dev. 1990;55:69–87. Available from: http://www.sciencedirect.com/science/article/pii/004763749090107Q.CrossRefPubMedGoogle Scholar
- 53.Nogueiras R, Habegger KM, Chaudhary N, Finan B, Banks AS, Dietrich MO, et al. Sirtuin 1 and Sirtuin 3: physiological modulators of metabolism. Physiol Rev. 2012;92:1479–514. https://doi.org/10.1152/physrev.00022.2011.
- 54.Allard JS, Heilbronn LK, Smith C, Hunt ND, Ingram DK, Ravussin E, et al. In vitro cellular adaptations of indicators of longevity in response to treatment with serum collected from humans on calorie restricted diets. PLoS one. Public Libr Sci. 2008;3:e3211. https://doi.org/10.1371/journal.pone.0003211.
- 57.•• Hoddy KK, Kroeger CM, Trepanowski JF, Barnosky AR, Bhutani S, Varady KA. Safety of alternate day fasting and effect on disordered eating behaviors. Nutr J. 2015;14:44. This study found that depression and binge eating scores decreased after 8 weeks of ADF.CrossRefPubMedPubMedCentralGoogle Scholar
- 58.Ridaura VK, Faith JJ, Rey FE, Cheng J, Alexis E, Kau AL, et al. Cultured gut microbiota from twins discordant for obesity modulate adiposity and metabolic phenotypes in mice. Science (80-. ). 2013;341.Google Scholar
- 59.Li G, Xie C, Lu S, Nichols RGG, Tian Y, Li L, et al. Intermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota. Cell Metab Cell Metab. 2017;26:672–85. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695033/pdf/nihms917439.pdf CrossRefPubMedGoogle Scholar
- 60.Shen R, Wang B, Giribaldi MG, Ayres J, Thomas JB, Montminy M. Neuronal energy-sensing pathway promotes energy balance by modulating disease tolerance. Proc. Natl. Acad. Sci.. 2016;113:E3307–14. Available from: http://www.pnas.org/content/113/23/E3307.abstract CrossRefPubMedPubMedCentralGoogle Scholar
- 61.Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol. Metab. 2014;25(1):42–52. https://doi.org/10.1016/j.tem.2013.09.002
- 63.Youm Y-H, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite [beta]-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2015;21:263–9.Google Scholar
- 64.Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Müller-Fielitz H, et al. The β-hydroxybutyrate receptor HCA 2 activates a neuroprotective subset of macrophages. Nat Commun Nature Publishing Group. 2014;5:3944.Google Scholar
- 65.Lanza IR, Zabielski P, Klaus KA, Morse DM, Heppelmann CJ, Bergen HR, et al. Chronic caloric restriction preserves mitochondrial function in senescence without increasing mitochondrial biogenesis. Cell Metab. 2012;16:777–88. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544078/.CrossRefPubMedPubMedCentralGoogle Scholar
- 67.Walsh ME, Shi Y, Van Remmen H. The effects of dietary restriction on oxidative stress in rodents. Free Radic Biol Med. 2014;66:88–99. Available from: http://www.sciencedirect.com/science/article/pii/S0891584913002475.CrossRefPubMedGoogle Scholar
- 68.Mattson MP. Hormesis defined. Ageing Res Rev. 2008;7:1–7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248601/.CrossRefPubMedGoogle Scholar
- 69.Ristow M, Schmeisser K. Mitohormesis: promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose Response. 2014;12:288–341. https://doi.org/10.2203/dose-response.13-035.Ristow.CrossRefPubMedPubMedCentralGoogle Scholar
- 71.Cerqueira FM, Chausse B, Kowaltowski AJ. Intermittent fasting effects on the central nervous system: how hunger modulates brain function. In: Preedy V, Patel VB, editors. Handb. Famine, Starvation, Nutr. Deprivation. Cham: Springer; 2017. p. 1–18. https://doi.org/10.1007/978-3-319-40007-5_29-1.
- 73.Lee JM, Wagner M, Xiao R, Kim KH, Feng D, Lazar MA, et al. Nutrient-sensing nuclear receptors coordinate autophagy. Nature. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2014;516:112. doi: https://doi.org/10.1038/nature13961.
- 74.Liu H-Y, Han J, Cao SY, Hong T, Zhuo D, Shi J, et al. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FOXO1-dependent expression of key autophagy genes by insulin. J Biol Chem. 2009;284:31484–92. Available from: http://www.jbc.org/content/284/45/31484.abstract.
- 75.Liu H, Javaheri A, Godar RJ, Murphy J, Ma X, Rohatgi N, et al. Intermittent fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway. Autophagy. Taylor & Francis. 2017;13:1952–68. https://doi.org/10.1080/15548627.2017.1368596.
- 76.• Harvie MN, Sims AH, Pegington M, Spence K, Mitchell A, Vaughan AA, et al. Intermittent energy restriction induces changes in breast gene expression and systemic metabolism. Breast Cancer Res. 2016;18:57. https://doi.org/10.1186/s13058-016-0714-4. This study compared the effects of CER and ICR on serum and urine metabolites as well as breast tissue gene expression.
- 77.Ong KR, Sims AH, Harvie M, Chapman M, Dunn WB, Broadhurst D, et al. Biomarkers of dietary energy restriction in women at increased risk of breast cancer. Cancer Prev Res. 2009;2:720–31. Available from: http://cancerpreventionresearch.aacrjournals.org/content/2/8/720.abstract
- 78.•• Kim K-H, Kim YH, Son JE, Lee JH, Kim S, Choe MS, et al. Intermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage. Cell Res The Author(s). 2017;27:1309–26. https://doi.org/10.1038/cr.2017.126 This study demonstrated a new mechanism for IF involving changes in AT inflammation in mice and evaluated correlations between genes involved in this pathway in human AT.
- 79.Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007. p. 819–26.Google Scholar
- 83.Kosteli A, Sugaru E, Haemmerle G, Martin JF, Lei J, Zechner R, et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest Am Soc Clin Investig. 2010;120:3466–79.Google Scholar
- 85.Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic and clinical implications. Hepatology. 2010;51:679–89. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575093/.CrossRefPubMedPubMedCentralGoogle Scholar
- 86.Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. Wiley Subscription Services, Inc., A Wiley Company. 2012;55:2005–23. https://doi.org/10.1002/hep.25762.
- 87.Hoeks J, van Herpen NA, Mensink M, Moonen-kornips E, van Beurden D, Hesselink MKC, et al. Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes. 2010;59:2117 LP-2125. Available from: http://diabetes.diabetesjournals.org/content/59/9/2117.abstract.
- 89.Li G, Brocker CN, Yan T, Xie C, Krausz KW, Xiang R, Gonzalez FJ Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha. Mol Metab. 2018;7:80–9. Available from: http://www.sciencedirect.com/science/article/pii/S2212877817306440.
- 91.Stote KS, Baer DJ, Spears K, Paul DR, Harris GK, Rumpler WV, et al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. Am J Clin Nutr. 2007;85:981–8.Google Scholar
- 93.Intermittent fasting trials. 2018 [cited 2018 Jan 3]. Available from: clinicaltrials.gov.